A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 197 participants.
Also called NCT01691989
- Study
- In this atlas
Overview
- Design
- Interventional study; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 197 participants
- Sponsor
- Registry
-
NCT01691989
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Argentina, Colombia, Guatemala, Mexico
- Registry status
- Completed
Technical summary
Registry record NCT01691989. Double masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2013-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy
- Condition
- Diabetes Mellitus Type 2
- Intervention (Drug)
- aleglitazar
- Intervention (Drug)
- placebo
- Lead sponsor
- Hoffmann-La Roche
Record details
- Record id
cardio:ct-nct01691989- Content hash
84d9d5dc58ccd6a700e438aa87af4c6cd28eb7c39afff7fd2ad63ab5dc94cd46